483 Response Patheon Pharmaceuticals Feb 2018

Kenneth Felkley FDA, Nicholas Paulin FDA, Lindsey Schwierjohann FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observation (via FDA 483) on 14 Feb 2018.

Product details

  • Category:
  • Inspection end: 14 Feb 2018
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart